Author:
Kinch Lisa N.,Brekken Deirdre L.,Phillips Margaret A.
Reference58 articles.
1. Almrud, J.J., Oliveira, M.A., Grishin, N.V., Phillips, M.A. and Hackert, M.L. (1999). Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural perspectives of antizyme binding. submitted.
2. Arrick, B.A., Griffith, O.W. and Cerami, A. (1981). Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis. J. Exp. Med. 153, 720–725.
3. Atamna, H. and Ginsburg, H. (1997). The malaria parasite supplies glutathione to its host cell: Investigation of glutatione transport and metabolism in human erythrocytes infected with P. falciparum. Eur. J. Biochem. 250, 670–679.
4. Bacchi, C.J., Garofalo, J. Ciminelli, M. Rattendi, D., Goldberg, B., McCann, P.P. and Yarlett, N. (1993). Resistance to DL-a-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense. Role of S-adenosylmethionine. Biochemical Pharmacol. 46, 471–481.
5. Bacchi, CJ, Nathan, H.C., Yarlett, N., Goldberg, B., McCann, P.P., Bitonti, A.J. and Sjoerdsma, A. (1992). Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor. Antimicrobial agents and Chemotherapy. 36, 2736–40.